turbulence – Talk Bio

Actionable Insights Powered by AI

Odyssey Therapeutics Abandons IPO Plans in Latest Sign of Tough Environment for Biotech Listings

Odyssey Therapeutics; IPO; biotech; withdrawal; SEC; market turbulence; autoimmune